Lauren Grygotis, Editor

Most Recent Articles by Lauren Grygotis, Editor

TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis

TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis

By

TNFi treatment is not associated with increased risk for cancer recurrence in patients with rheumatoid arthritis

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

By

Data indicate that drug-naive new onset systemic lupus erythematosus was likely to involve silent cardiac impairment.

FDA Action Plan Released to Promote Competition, Affordability of Biosimilars

FDA Action Plan Released to Promote Competition, Affordability of Biosimilars

By

The FDA has released a Biosimilar Action Plan to promote competition and affordability across the market for biologic and biosimilar products.

Positive Phase 3 Data Announced for Ixekizumab in Ankylosing Spondylitis

Positive Phase 3 Data Announced for Ixekizumab in Ankylosing Spondylitis

By

Results from a phase 3 study show positive results for ixekizumab in patients with ankylosing spondylitis.

Etanercept, Infliximab, Adalimumab Biosimilars Show Similar Efficacy vs Reference Products in RA

Etanercept, Infliximab, Adalimumab Biosimilars Show Similar Efficacy vs Reference Products in RA

By

A pooled analysis compared the efficacy and safety of anti-TNF biosimilars with their reference products.

More Articles by Lauren Grygotis, Editor

Sign Up for Free e-newsletters